Effect of Smart Phone Application on the Individualized Management of Chinese Diabetic Patients
- Conditions
- Diabetes Mellitus
- Interventions
- Device: Welltang App
- Registration Number
- NCT02589730
- Lead Sponsor
- Shanghai Geping Information Technology Company
- Brief Summary
The purpose of this study was to explore a model suitable for the individualized diabetic management based on the mobile application coaching and demonstrate its effect among the diabetic mellitus population.
- Detailed Description
The enrolled patients will be randomly divided into three groups: group of online self management, group of online mutual management and the control group. The estimated sample size was 78 patients for each group. All the patients attend two follow-up visits at the hospital, after 3 and 6 months. The data will be collected by a full-time recorder and analyzed using specific statistical software. The enumeration data are analyzed by chi-square test, while the measurement data are analyzed by one-way ANOVA.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 234
- Physician diagnosis of DM for more than 6 months;
- Glycated hemoglobin more than or equal to 8% within 3 months;
- Age:18-65 years.
- Insulin pump users;
- Pregnant;
- Active substance, alcohol, or drug abuser;
- Psychotic or schizophrenic under active care;
- Severe hearing or visual impairment and other complications;
- Drug users (such as glucocorticoid or thyroid hormone) 3 months before the enrollment;
- No smartphone access.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description online mutual management Welltang App The patients received the online coaching of a doctor and diabetes educator via smart phone based welltang app. online self-management Welltang App The patients received the online coaching of a doctor alone via smart phone based welltang app.
- Primary Outcome Measures
Name Time Method change in glycated hemoglobin levels six months
- Secondary Outcome Measures
Name Time Method change of hepatic function six months change in lipid profile levels six months change of urinary albumin creatinine rate six months change of blood creatine six months change of blood urea nitrogen six months change in scores measured by MKT six months
Trial Locations
- Locations (1)
Shanghai Six People's Hospital
🇨🇳Shanghai, Shanghai, China